Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OCULUS Surgical is the ophthalmic surgery-focused business of OCULUS, specializing in visualization and access devices used in vitreoretinal and glaucoma procedures. The company originated from OCULUS Optikgeräte GmbH’s development of the SDI/BIOM non-contact wide-angle viewing system and was formalized as a Florida subsidiary in April 2012 to support direct distribution in the Americas. Its portfolio includes BIOM, SDI, GONIO ready, disposable optic sets, and related surgical lenses for use in ophthalmic operating rooms. The business is focused on commercial medical devices rather than therapeutics, with products aimed at improving intraoperative visualization, workflow, and surgeon ergonomics. OCULUS Surgical operates within the broader OCULUS group, a long-established German ophthalmic device manufacturer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OCULUS Surgical.